Compare VREX & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VREX | CYRX |
|---|---|---|
| Founded | 2016 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 783.5M | 883.3M |
| IPO Year | 2016 | 2008 |
| Metric | VREX | CYRX |
|---|---|---|
| Price | $18.41 | $17.85 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | $18.90 | ★ $19.78 |
| AVG Volume (30 Days) | 457.5K | ★ 649.3K |
| Earning Date | 11-17-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | ★ 0.23 | N/A |
| Revenue | ★ $811,000,000.00 | $176,177,000.00 |
| Revenue This Year | $2.52 | $10.96 |
| Revenue Next Year | $3.97 | $10.10 |
| P/E Ratio | $80.07 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.09 | $7.61 |
| 52 Week High | $18.63 | $18.73 |
| Indicator | VREX | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 59.72 | 57.49 |
| Support Level | $18.35 | $14.55 |
| Resistance Level | $18.63 | $18.17 |
| Average True Range (ATR) | 0.05 | 0.72 |
| MACD | -0.06 | 0.04 |
| Stochastic Oscillator | 36.67 | 66.91 |
Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.